Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Proteins | 23 | 2020 | 730 | 4.180 |
Why?
|
Software | 16 | 2020 | 367 | 3.950 |
Why?
|
Algorithms | 25 | 2020 | 976 | 3.880 |
Why?
|
Regulatory Sequences, Nucleic Acid | 8 | 2024 | 96 | 3.630 |
Why?
|
Computational Biology | 24 | 2020 | 331 | 3.550 |
Why?
|
Genome, Human | 12 | 2023 | 222 | 3.330 |
Why?
|
Molecular Docking Simulation | 8 | 2020 | 73 | 3.090 |
Why?
|
Transcription Factors | 17 | 2024 | 1470 | 2.970 |
Why?
|
Epigenesis, Genetic | 10 | 2024 | 357 | 2.590 |
Why?
|
Gene Expression Regulation | 21 | 2024 | 1547 | 2.500 |
Why?
|
RNA, Small Interfering | 32 | 2025 | 855 | 2.260 |
Why?
|
Protein Interaction Mapping | 7 | 2020 | 68 | 2.070 |
Why?
|
Chromatin | 13 | 2023 | 599 | 2.060 |
Why?
|
Genomics | 8 | 2023 | 318 | 2.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 13 | 2025 | 262 | 1.980 |
Why?
|
Transcription, Genetic | 12 | 2021 | 844 | 1.940 |
Why?
|
Histones | 14 | 2021 | 457 | 1.800 |
Why?
|
Binding Sites | 24 | 2023 | 881 | 1.580 |
Why?
|
Regulatory Elements, Transcriptional | 4 | 2024 | 37 | 1.580 |
Why?
|
Databases, Genetic | 7 | 2022 | 83 | 1.570 |
Why?
|
Sequence Analysis, DNA | 11 | 2016 | 393 | 1.560 |
Why?
|
Sequence Analysis, RNA | 7 | 2025 | 159 | 1.520 |
Why?
|
Evolution, Molecular | 8 | 2025 | 298 | 1.420 |
Why?
|
Models, Molecular | 18 | 2018 | 1128 | 1.410 |
Why?
|
Protein Binding | 21 | 2020 | 1554 | 1.410 |
Why?
|
Protein Conformation | 19 | 2018 | 763 | 1.400 |
Why?
|
Prefrontal Cortex | 7 | 2019 | 107 | 1.390 |
Why?
|
Peptides | 8 | 2020 | 547 | 1.370 |
Why?
|
Drosophila Proteins | 24 | 2021 | 679 | 1.330 |
Why?
|
Promoter Regions, Genetic | 15 | 2025 | 650 | 1.320 |
Why?
|
DNA Transposable Elements | 12 | 2023 | 126 | 1.260 |
Why?
|
Drosophila melanogaster | 21 | 2021 | 481 | 1.210 |
Why?
|
Genome-Wide Association Study | 6 | 2023 | 331 | 1.170 |
Why?
|
Mammals | 5 | 2023 | 208 | 1.120 |
Why?
|
Animals | 79 | 2025 | 19601 | 1.110 |
Why?
|
Databases, Protein | 8 | 2018 | 46 | 1.100 |
Why?
|
Nucleotide Motifs | 5 | 2022 | 50 | 1.080 |
Why?
|
Chromatin Assembly and Disassembly | 6 | 2021 | 229 | 1.060 |
Why?
|
Argonaute Proteins | 18 | 2021 | 129 | 1.060 |
Why?
|
Receptors, Antigen, T-Cell | 4 | 2017 | 281 | 0.970 |
Why?
|
Transcriptome | 6 | 2022 | 338 | 0.940 |
Why?
|
Chromatin Immunoprecipitation | 9 | 2014 | 144 | 0.890 |
Why?
|
DNA | 6 | 2012 | 806 | 0.890 |
Why?
|
Genome | 9 | 2021 | 257 | 0.880 |
Why?
|
Enhancer Elements, Genetic | 2 | 2020 | 102 | 0.800 |
Why?
|
Humans | 67 | 2024 | 59282 | 0.770 |
Why?
|
Gene Silencing | 11 | 2025 | 378 | 0.760 |
Why?
|
Huntington Disease | 4 | 2015 | 146 | 0.760 |
Why?
|
RNA Splicing | 5 | 2019 | 159 | 0.750 |
Why?
|
Sequence Alignment | 6 | 2016 | 288 | 0.750 |
Why?
|
RNA, Messenger | 16 | 2020 | 1464 | 0.690 |
Why?
|
Thermodynamics | 10 | 2017 | 191 | 0.690 |
Why?
|
Transcription Initiation Site | 7 | 2021 | 48 | 0.660 |
Why?
|
Alu Elements | 1 | 2019 | 9 | 0.650 |
Why?
|
Peptide Initiation Factors | 8 | 2019 | 31 | 0.650 |
Why?
|
RNA, Small Untranslated | 2 | 2016 | 18 | 0.650 |
Why?
|
Molecular Sequence Annotation | 3 | 2019 | 61 | 0.650 |
Why?
|
Whole Genome Sequencing | 1 | 2019 | 63 | 0.640 |
Why?
|
DNA Methylation | 7 | 2021 | 271 | 0.630 |
Why?
|
Germ Cells | 8 | 2021 | 97 | 0.630 |
Why?
|
Brain | 3 | 2024 | 1487 | 0.630 |
Why?
|
RNA Polymerase II | 2 | 2018 | 72 | 0.620 |
Why?
|
Neurons | 9 | 2024 | 863 | 0.620 |
Why?
|
MicroRNAs | 11 | 2020 | 616 | 0.610 |
Why?
|
Databases, Factual | 3 | 2017 | 813 | 0.590 |
Why?
|
Protein Interaction Domains and Motifs | 2 | 2020 | 83 | 0.580 |
Why?
|
Gene Regulatory Networks | 3 | 2020 | 146 | 0.560 |
Why?
|
CRISPR-Cas Systems | 6 | 2021 | 333 | 0.540 |
Why?
|
Influenza A Virus, H7N9 Subtype | 2 | 2013 | 7 | 0.540 |
Why?
|
Antibodies, Neutralizing | 2 | 2017 | 177 | 0.530 |
Why?
|
Genes, Viral | 2 | 2013 | 55 | 0.530 |
Why?
|
Organ Specificity | 5 | 2021 | 182 | 0.520 |
Why?
|
Cluster Analysis | 5 | 2016 | 243 | 0.520 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2017 | 132 | 0.510 |
Why?
|
Mutation | 13 | 2020 | 2452 | 0.510 |
Why?
|
Internet | 8 | 2020 | 449 | 0.500 |
Why?
|
Chromosome Breakpoints | 1 | 2015 | 5 | 0.500 |
Why?
|
Genomic Structural Variation | 1 | 2015 | 4 | 0.500 |
Why?
|
Mice | 29 | 2025 | 10251 | 0.490 |
Why?
|
Biological Evolution | 3 | 2020 | 114 | 0.490 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 2 | 2014 | 119 | 0.470 |
Why?
|
Antigens, CD1d | 1 | 2014 | 28 | 0.470 |
Why?
|
Viral Envelope Proteins | 2 | 2017 | 100 | 0.470 |
Why?
|
Epigenomics | 3 | 2021 | 54 | 0.460 |
Why?
|
Exons | 4 | 2018 | 190 | 0.460 |
Why?
|
Gene Ontology | 3 | 2021 | 38 | 0.460 |
Why?
|
Antigens, CD1 | 1 | 2014 | 42 | 0.460 |
Why?
|
RNA Processing, Post-Transcriptional | 4 | 2018 | 88 | 0.450 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2014 | 70 | 0.450 |
Why?
|
Vitamins | 1 | 2014 | 74 | 0.450 |
Why?
|
Histocompatibility Antigens | 2 | 2013 | 107 | 0.440 |
Why?
|
ran GTP-Binding Protein | 1 | 2013 | 4 | 0.440 |
Why?
|
Benchmarking | 3 | 2020 | 135 | 0.430 |
Why?
|
Protein Interaction Maps | 1 | 2013 | 33 | 0.430 |
Why?
|
Nuclear Proteins | 5 | 2021 | 750 | 0.430 |
Why?
|
Multiprotein Complexes | 2 | 2014 | 153 | 0.430 |
Why?
|
Human Development | 1 | 2013 | 9 | 0.420 |
Why?
|
Hepatitis C, Chronic | 1 | 2014 | 88 | 0.420 |
Why?
|
Sea Urchins | 1 | 2013 | 35 | 0.420 |
Why?
|
Structural Homology, Protein | 3 | 2020 | 20 | 0.410 |
Why?
|
Encyclopedias as Topic | 1 | 2012 | 5 | 0.410 |
Why?
|
Phascolarctidae | 2 | 2025 | 6 | 0.410 |
Why?
|
YY1 Transcription Factor | 1 | 2012 | 13 | 0.400 |
Why?
|
Embryonic Stem Cells | 4 | 2014 | 150 | 0.400 |
Why?
|
Models, Genetic | 2 | 2014 | 255 | 0.390 |
Why?
|
Liver Neoplasms | 3 | 2021 | 277 | 0.390 |
Why?
|
Gene Expression Regulation, Developmental | 5 | 2021 | 618 | 0.390 |
Why?
|
Liver Transplantation | 1 | 2014 | 207 | 0.390 |
Why?
|
Caenorhabditis elegans | 5 | 2018 | 623 | 0.380 |
Why?
|
Peptide Library | 1 | 2011 | 35 | 0.380 |
Why?
|
RNA Helicases | 5 | 2019 | 88 | 0.380 |
Why?
|
Ligands | 6 | 2020 | 410 | 0.370 |
Why?
|
Chromosome Mapping | 5 | 2014 | 284 | 0.370 |
Why?
|
Cell Line | 9 | 2020 | 1968 | 0.360 |
Why?
|
Models, Statistical | 2 | 2012 | 298 | 0.360 |
Why?
|
Caenorhabditis elegans Proteins | 5 | 2018 | 397 | 0.360 |
Why?
|
Chromosomal Proteins, Non-Histone | 6 | 2021 | 168 | 0.360 |
Why?
|
Amino Acid Sequence | 9 | 2020 | 1552 | 0.350 |
Why?
|
RNA Polymerase III | 2 | 2021 | 9 | 0.350 |
Why?
|
Models, Chemical | 2 | 2010 | 135 | 0.350 |
Why?
|
Phylogeny | 4 | 2023 | 336 | 0.340 |
Why?
|
Testis | 4 | 2023 | 135 | 0.330 |
Why?
|
Antibodies, Monoclonal | 1 | 2014 | 837 | 0.330 |
Why?
|
Nucleosomes | 5 | 2014 | 184 | 0.330 |
Why?
|
Ovary | 6 | 2019 | 98 | 0.320 |
Why?
|
Retroelements | 4 | 2015 | 39 | 0.320 |
Why?
|
Spermatogenesis | 3 | 2023 | 66 | 0.320 |
Why?
|
Viral Proteins | 4 | 2015 | 252 | 0.320 |
Why?
|
Polycomb Repressive Complex 2 | 2 | 2021 | 16 | 0.310 |
Why?
|
Biomarkers | 1 | 2014 | 1305 | 0.310 |
Why?
|
Artificial Intelligence | 1 | 2011 | 155 | 0.310 |
Why?
|
Drosophila | 5 | 2023 | 421 | 0.300 |
Why?
|
Gene Editing | 4 | 2021 | 299 | 0.300 |
Why?
|
Base Sequence | 12 | 2020 | 1300 | 0.300 |
Why?
|
Neoplasms | 2 | 2015 | 1240 | 0.290 |
Why?
|
Frontotemporal Dementia | 2 | 2023 | 136 | 0.290 |
Why?
|
Base Composition | 2 | 2021 | 27 | 0.290 |
Why?
|
Genome, Insect | 3 | 2013 | 31 | 0.290 |
Why?
|
Hepatocytes | 2 | 2021 | 196 | 0.280 |
Why?
|
Adenine | 2 | 2020 | 47 | 0.280 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2021 | 411 | 0.280 |
Why?
|
Chromosomes, Human | 3 | 2021 | 53 | 0.280 |
Why?
|
RNA, Fungal | 2 | 2025 | 38 | 0.270 |
Why?
|
Neoplasm Proteins | 2 | 2021 | 277 | 0.270 |
Why?
|
RNA-Induced Silencing Complex | 6 | 2011 | 67 | 0.260 |
Why?
|
Protein Multimerization | 2 | 2020 | 169 | 0.260 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2019 | 168 | 0.260 |
Why?
|
DEAD-box RNA Helicases | 4 | 2018 | 79 | 0.260 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2006 | 8 | 0.260 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2019 | 289 | 0.260 |
Why?
|
Molecular Sequence Data | 11 | 2016 | 1949 | 0.250 |
Why?
|
DNA-Binding Proteins | 3 | 2021 | 1151 | 0.240 |
Why?
|
Amino Acid Motifs | 2 | 2021 | 150 | 0.240 |
Why?
|
Endogenous Retroviruses | 1 | 2025 | 11 | 0.240 |
Why?
|
Research Design | 2 | 2020 | 555 | 0.240 |
Why?
|
Mice, Inbred C57BL | 8 | 2021 | 3220 | 0.240 |
Why?
|
Amyotrophic Lateral Sclerosis | 2 | 2023 | 480 | 0.230 |
Why?
|
RNA, Transfer | 1 | 2025 | 78 | 0.230 |
Why?
|
Schizosaccharomyces | 2 | 2018 | 104 | 0.230 |
Why?
|
Exoribonucleases | 2 | 2016 | 25 | 0.220 |
Why?
|
Antibodies, Viral | 2 | 2017 | 291 | 0.220 |
Why?
|
Gene Expression Profiling | 9 | 2020 | 716 | 0.220 |
Why?
|
Protein Folding | 4 | 2003 | 259 | 0.220 |
Why?
|
Heterochromatin | 4 | 2018 | 84 | 0.220 |
Why?
|
Cholangitis, Sclerosing | 1 | 2023 | 12 | 0.220 |
Why?
|
Alleles | 5 | 2020 | 410 | 0.220 |
Why?
|
Nucleotides | 2 | 2020 | 44 | 0.210 |
Why?
|
Primates | 1 | 2023 | 42 | 0.210 |
Why?
|
Methylation | 5 | 2019 | 123 | 0.210 |
Why?
|
Genes, Insect | 2 | 2020 | 90 | 0.200 |
Why?
|
Deoxyribonuclease I | 2 | 2012 | 40 | 0.200 |
Why?
|
Placenta | 1 | 2023 | 55 | 0.200 |
Why?
|
Models, Biological | 9 | 2020 | 1140 | 0.200 |
Why?
|
Male | 21 | 2025 | 27727 | 0.200 |
Why?
|
RNA Interference | 3 | 2011 | 590 | 0.200 |
Why?
|
Female | 20 | 2023 | 30695 | 0.200 |
Why?
|
Olfactory Bulb | 1 | 2022 | 15 | 0.200 |
Why?
|
Oligonucleotides | 1 | 2004 | 215 | 0.200 |
Why?
|
Olfactory Receptor Neurons | 1 | 2022 | 13 | 0.190 |
Why?
|
Homeodomain Proteins | 2 | 2014 | 254 | 0.190 |
Why?
|
Antibodies | 3 | 2017 | 179 | 0.190 |
Why?
|
Genome Components | 1 | 2021 | 5 | 0.190 |
Why?
|
TATA Box | 1 | 2021 | 11 | 0.190 |
Why?
|
Cell Differentiation | 4 | 2021 | 1298 | 0.190 |
Why?
|
Genes, Essential | 1 | 2021 | 18 | 0.190 |
Why?
|
Short Interspersed Nucleotide Elements | 1 | 2021 | 4 | 0.190 |
Why?
|
Introns | 2 | 2018 | 104 | 0.180 |
Why?
|
Repressor Proteins | 2 | 2021 | 332 | 0.180 |
Why?
|
Hepatoblastoma | 1 | 2021 | 8 | 0.180 |
Why?
|
Influenza, Human | 2 | 2013 | 191 | 0.180 |
Why?
|
RNA Cleavage | 3 | 2015 | 11 | 0.180 |
Why?
|
Meiosis | 3 | 2023 | 62 | 0.180 |
Why?
|
Manduca | 1 | 2020 | 27 | 0.170 |
Why?
|
Position-Specific Scoring Matrices | 1 | 2020 | 7 | 0.170 |
Why?
|
Muscular Atrophy | 1 | 2020 | 25 | 0.170 |
Why?
|
Dipeptides | 2 | 2023 | 60 | 0.170 |
Why?
|
Gestational Age | 1 | 2021 | 178 | 0.170 |
Why?
|
Saccharomyces cerevisiae | 1 | 2025 | 537 | 0.170 |
Why?
|
Protein Conformation, beta-Strand | 1 | 2020 | 10 | 0.170 |
Why?
|
Data Curation | 1 | 2020 | 4 | 0.170 |
Why?
|
Protein Conformation, alpha-Helical | 1 | 2020 | 21 | 0.170 |
Why?
|
Genetic Therapy | 2 | 2018 | 733 | 0.170 |
Why?
|
Habenula | 1 | 2020 | 15 | 0.170 |
Why?
|
Gammaretrovirus | 1 | 2019 | 7 | 0.170 |
Why?
|
Genetic Vectors | 4 | 2018 | 807 | 0.170 |
Why?
|
Interpeduncular Nucleus | 1 | 2020 | 21 | 0.160 |
Why?
|
Sequence Homology, Amino Acid | 4 | 2014 | 356 | 0.160 |
Why?
|
Cross-Linking Reagents | 2 | 2018 | 117 | 0.160 |
Why?
|
Uridine | 2 | 2020 | 16 | 0.160 |
Why?
|
RNA | 2 | 2014 | 400 | 0.160 |
Why?
|
Endoribonucleases | 2 | 2019 | 53 | 0.160 |
Why?
|
Phenotype | 6 | 2022 | 1136 | 0.160 |
Why?
|
Mathematical Computing | 1 | 1998 | 11 | 0.160 |
Why?
|
Nicotine | 1 | 2020 | 113 | 0.150 |
Why?
|
Binding Sites, Antibody | 1 | 1998 | 23 | 0.150 |
Why?
|
Antigen Presentation | 2 | 2014 | 223 | 0.150 |
Why?
|
Receptors, Fc | 1 | 1998 | 21 | 0.150 |
Why?
|
Mental Disorders | 2 | 2024 | 717 | 0.150 |
Why?
|
A549 Cells | 1 | 2018 | 36 | 0.150 |
Why?
|
User-Computer Interface | 1 | 1999 | 123 | 0.150 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2020 | 119 | 0.150 |
Why?
|
Nerve Tissue Proteins | 3 | 2016 | 416 | 0.150 |
Why?
|
Spermatozoa | 2 | 2025 | 253 | 0.150 |
Why?
|
Sex Determination Analysis | 1 | 2018 | 5 | 0.150 |
Why?
|
Sex Chromosomes | 1 | 2018 | 8 | 0.150 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 1998 | 44 | 0.150 |
Why?
|
Machine Learning | 1 | 2020 | 153 | 0.150 |
Why?
|
Disease Models, Animal | 4 | 2023 | 2046 | 0.150 |
Why?
|
Dosage Compensation, Genetic | 1 | 2018 | 22 | 0.150 |
Why?
|
Open Reading Frames | 1 | 2018 | 80 | 0.150 |
Why?
|
Base Pairing | 3 | 2018 | 39 | 0.150 |
Why?
|
Epitopes | 2 | 2017 | 285 | 0.140 |
Why?
|
Viral Hepatitis Vaccines | 1 | 2017 | 3 | 0.140 |
Why?
|
Spliceosomes | 1 | 2018 | 41 | 0.140 |
Why?
|
Human Genome Project | 1 | 1997 | 4 | 0.140 |
Why?
|
Pregnancy | 4 | 2023 | 2202 | 0.140 |
Why?
|
Dependovirus | 3 | 2018 | 652 | 0.140 |
Why?
|
Calorimetry | 1 | 1997 | 40 | 0.140 |
Why?
|
Cognition | 2 | 2019 | 455 | 0.140 |
Why?
|
Schizophrenia | 1 | 2019 | 242 | 0.140 |
Why?
|
Ribonuclease III | 3 | 2012 | 82 | 0.140 |
Why?
|
Biotechnology | 1 | 1997 | 42 | 0.140 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2017 | 475 | 0.140 |
Why?
|
alpha 1-Antitrypsin | 1 | 2018 | 87 | 0.140 |
Why?
|
alpha 1-Antitrypsin Deficiency | 1 | 2018 | 62 | 0.140 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2017 | 55 | 0.140 |
Why?
|
Crystallography, X-Ray | 3 | 2014 | 424 | 0.140 |
Why?
|
RNA-Binding Proteins | 3 | 2019 | 384 | 0.140 |
Why?
|
fas Receptor | 1 | 2017 | 55 | 0.140 |
Why?
|
Liver Neoplasms, Experimental | 1 | 2016 | 32 | 0.130 |
Why?
|
Metadata | 1 | 2016 | 14 | 0.130 |
Why?
|
Cell Line, Tumor | 6 | 2019 | 1368 | 0.130 |
Why?
|
DNA Footprinting | 2 | 2014 | 17 | 0.130 |
Why?
|
Eukaryotic Initiation Factors | 3 | 2010 | 29 | 0.130 |
Why?
|
Genetic Variation | 3 | 2012 | 357 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2016 | 96 | 0.130 |
Why?
|
Ribonucleoproteins | 2 | 2018 | 112 | 0.130 |
Why?
|
Hepacivirus | 1 | 2017 | 140 | 0.130 |
Why?
|
Enhancer of Zeste Homolog 2 Protein | 1 | 2015 | 15 | 0.130 |
Why?
|
Mitochondria | 1 | 2019 | 343 | 0.130 |
Why?
|
Bacterial Proteins | 4 | 2015 | 732 | 0.130 |
Why?
|
RNA, Nuclear | 1 | 2015 | 13 | 0.120 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2016 | 205 | 0.120 |
Why?
|
Polynucleotide Adenylyltransferase | 1 | 2015 | 14 | 0.120 |
Why?
|
Recombinational DNA Repair | 1 | 2015 | 19 | 0.120 |
Why?
|
DNA End-Joining Repair | 1 | 2015 | 23 | 0.120 |
Why?
|
Cell Nucleus | 4 | 2021 | 606 | 0.120 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 147 | 0.120 |
Why?
|
Genes, Tumor Suppressor | 1 | 2015 | 70 | 0.120 |
Why?
|
Apoptosis | 1 | 2020 | 1032 | 0.120 |
Why?
|
Vaccinia virus | 1 | 2015 | 70 | 0.120 |
Why?
|
Oncogenes | 1 | 2015 | 66 | 0.120 |
Why?
|
Infant | 3 | 2019 | 1486 | 0.120 |
Why?
|
Caenorhabditis | 1 | 2014 | 14 | 0.120 |
Why?
|
Transgenes | 2 | 2018 | 177 | 0.120 |
Why?
|
Huntingtin Protein | 1 | 2015 | 138 | 0.120 |
Why?
|
Neostriatum | 1 | 2014 | 25 | 0.120 |
Why?
|
Cytosine | 2 | 2011 | 31 | 0.120 |
Why?
|
Helminth Proteins | 1 | 2014 | 39 | 0.120 |
Why?
|
Galactosylceramides | 1 | 2014 | 11 | 0.120 |
Why?
|
Adult | 7 | 2019 | 15663 | 0.120 |
Why?
|
Middle Aged | 7 | 2019 | 16310 | 0.120 |
Why?
|
Child, Preschool | 3 | 2019 | 1782 | 0.120 |
Why?
|
Corpus Striatum | 1 | 2015 | 93 | 0.110 |
Why?
|
Non-alcoholic Fatty Liver Disease | 1 | 2015 | 71 | 0.110 |
Why?
|
Genes, Homeobox | 1 | 2014 | 23 | 0.110 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2014 | 124 | 0.110 |
Why?
|
Glycosylation | 1 | 2014 | 129 | 0.110 |
Why?
|
Lysine | 2 | 2012 | 74 | 0.110 |
Why?
|
Support Vector Machine | 1 | 2013 | 21 | 0.110 |
Why?
|
Influenza in Birds | 1 | 2013 | 3 | 0.110 |
Why?
|
Columbidae | 1 | 2013 | 11 | 0.110 |
Why?
|
Prognosis | 2 | 2016 | 1599 | 0.110 |
Why?
|
Aged | 5 | 2019 | 13412 | 0.110 |
Why?
|
Proteolysis | 1 | 2014 | 136 | 0.110 |
Why?
|
Reassortant Viruses | 1 | 2013 | 9 | 0.110 |
Why?
|
Histone Acetyltransferases | 1 | 2013 | 56 | 0.110 |
Why?
|
Molecular Conformation | 1 | 2013 | 133 | 0.110 |
Why?
|
Mutation Rate | 1 | 2013 | 19 | 0.110 |
Why?
|
Infant, Newborn | 2 | 2019 | 1283 | 0.110 |
Why?
|
Histone Deacetylases | 1 | 2013 | 62 | 0.110 |
Why?
|
Gene Rearrangement | 1 | 2013 | 38 | 0.110 |
Why?
|
T-Lymphocytes | 1 | 1998 | 983 | 0.110 |
Why?
|
Macaca mulatta | 2 | 2023 | 228 | 0.110 |
Why?
|
Area Under Curve | 1 | 2013 | 141 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-myb | 1 | 2013 | 11 | 0.110 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2013 | 29 | 0.100 |
Why?
|
Fertility | 3 | 2020 | 78 | 0.100 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2015 | 167 | 0.100 |
Why?
|
RNA, Viral | 1 | 2014 | 259 | 0.100 |
Why?
|
Poly A | 1 | 2012 | 27 | 0.100 |
Why?
|
Recurrence | 1 | 2014 | 602 | 0.100 |
Why?
|
Wnt Signaling Pathway | 1 | 2013 | 71 | 0.100 |
Why?
|
Down-Regulation | 3 | 2023 | 305 | 0.100 |
Why?
|
Double-Blind Method | 1 | 2014 | 715 | 0.100 |
Why?
|
Child | 4 | 2019 | 4173 | 0.100 |
Why?
|
Adolescent | 4 | 2019 | 5822 | 0.100 |
Why?
|
Entropy | 1 | 2012 | 21 | 0.100 |
Why?
|
Genome, Fungal | 1 | 2012 | 40 | 0.100 |
Why?
|
Antigen-Antibody Complex | 1 | 2012 | 51 | 0.100 |
Why?
|
Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2011 | 17 | 0.100 |
Why?
|
Replication Origin | 1 | 2012 | 35 | 0.100 |
Why?
|
Proteome | 1 | 2012 | 141 | 0.090 |
Why?
|
Actins | 1 | 2013 | 258 | 0.090 |
Why?
|
Enzyme Inhibitors | 3 | 2016 | 349 | 0.090 |
Why?
|
Genetic Loci | 3 | 2019 | 107 | 0.090 |
Why?
|
Lung Neoplasms | 1 | 2017 | 582 | 0.090 |
Why?
|
Trans-Activators | 1 | 2013 | 300 | 0.090 |
Why?
|
Diet, Protein-Restricted | 1 | 2010 | 12 | 0.090 |
Why?
|
Genomic Imprinting | 1 | 2010 | 48 | 0.090 |
Why?
|
Telomere | 1 | 2010 | 50 | 0.090 |
Why?
|
Gene Expression | 3 | 2011 | 808 | 0.090 |
Why?
|
DNA, Circular | 1 | 2010 | 7 | 0.090 |
Why?
|
Protein Structure, Secondary | 1 | 2011 | 253 | 0.090 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2010 | 111 | 0.090 |
Why?
|
Antibody Specificity | 1 | 2010 | 100 | 0.090 |
Why?
|
Oocytes | 1 | 2011 | 193 | 0.090 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2012 | 438 | 0.090 |
Why?
|
Antigens, Viral | 3 | 1999 | 129 | 0.080 |
Why?
|
Young Adult | 3 | 2019 | 4266 | 0.080 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2011 | 209 | 0.080 |
Why?
|
RNA Transport | 1 | 2009 | 29 | 0.080 |
Why?
|
RNA Stability | 1 | 2010 | 96 | 0.080 |
Why?
|
Dimerization | 2 | 2013 | 144 | 0.080 |
Why?
|
Signal Transduction | 5 | 2018 | 2888 | 0.080 |
Why?
|
Lipid Metabolism | 1 | 2010 | 203 | 0.080 |
Why?
|
Ovarian Follicle | 1 | 2009 | 39 | 0.080 |
Why?
|
Nanotechnology | 1 | 2010 | 127 | 0.080 |
Why?
|
C9orf72 Protein | 2 | 2023 | 104 | 0.080 |
Why?
|
Codon, Nonsense | 2 | 2020 | 51 | 0.080 |
Why?
|
Follow-Up Studies | 1 | 2014 | 2337 | 0.080 |
Why?
|
Central Nervous System | 1 | 2010 | 193 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 1 | 2012 | 673 | 0.080 |
Why?
|
Endonucleases | 2 | 2021 | 80 | 0.070 |
Why?
|
Endopeptidases | 2 | 2000 | 68 | 0.070 |
Why?
|
Aged, 80 and over | 2 | 2019 | 5128 | 0.070 |
Why?
|
Pachytene Stage | 2 | 2020 | 7 | 0.070 |
Why?
|
Genotype | 2 | 2023 | 617 | 0.070 |
Why?
|
HLA-A2 Antigen | 2 | 2014 | 64 | 0.070 |
Why?
|
Protein Structure, Tertiary | 3 | 2011 | 656 | 0.070 |
Why?
|
RNA, Antisense | 2 | 2019 | 49 | 0.060 |
Why?
|
NF-E2-Related Factor 1 | 1 | 2006 | 1 | 0.060 |
Why?
|
Time Factors | 2 | 2011 | 3614 | 0.060 |
Why?
|
Sp1 Transcription Factor | 1 | 2006 | 21 | 0.060 |
Why?
|
GA-Binding Protein Transcription Factor | 1 | 2006 | 16 | 0.060 |
Why?
|
Epitopes, T-Lymphocyte | 2 | 2014 | 176 | 0.060 |
Why?
|
Gene Knockdown Techniques | 2 | 2020 | 194 | 0.060 |
Why?
|
Macromolecular Substances | 2 | 2003 | 160 | 0.060 |
Why?
|
Early Growth Response Protein 2 | 1 | 2005 | 8 | 0.060 |
Why?
|
Receptors, Adenosine A2 | 1 | 2005 | 4 | 0.060 |
Why?
|
Genes, MHC Class I | 1 | 2005 | 27 | 0.060 |
Why?
|
Random Allocation | 1 | 2006 | 192 | 0.060 |
Why?
|
Crystallization | 2 | 2003 | 97 | 0.060 |
Why?
|
Metabolic Networks and Pathways | 2 | 2016 | 74 | 0.060 |
Why?
|
Proviruses | 1 | 2025 | 26 | 0.060 |
Why?
|
Databases, Nucleic Acid | 1 | 2004 | 8 | 0.060 |
Why?
|
3' Untranslated Regions | 1 | 2025 | 89 | 0.060 |
Why?
|
Access to Information | 1 | 2004 | 30 | 0.060 |
Why?
|
Response Elements | 1 | 2004 | 43 | 0.060 |
Why?
|
Autopsy | 2 | 2014 | 53 | 0.060 |
Why?
|
Molecular Structure | 2 | 2003 | 374 | 0.060 |
Why?
|
Cloning, Molecular | 1 | 2025 | 381 | 0.060 |
Why?
|
Conserved Sequence | 1 | 2004 | 169 | 0.060 |
Why?
|
Interleukin-18 | 1 | 2004 | 71 | 0.060 |
Why?
|
HEK293 Cells | 2 | 2020 | 586 | 0.060 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2004 | 109 | 0.060 |
Why?
|
Monte Carlo Method | 1 | 2004 | 87 | 0.050 |
Why?
|
Publishing | 1 | 2004 | 90 | 0.050 |
Why?
|
Information Dissemination | 1 | 2004 | 112 | 0.050 |
Why?
|
Mice, Knockout | 3 | 2016 | 1985 | 0.050 |
Why?
|
Receptors, Cell Surface | 2 | 2016 | 428 | 0.050 |
Why?
|
Spermatocytes | 1 | 2023 | 10 | 0.050 |
Why?
|
Systems Integration | 1 | 2003 | 26 | 0.050 |
Why?
|
DNA Repeat Expansion | 1 | 2023 | 53 | 0.050 |
Why?
|
Rats | 2 | 2014 | 1909 | 0.050 |
Why?
|
Semen | 1 | 2023 | 42 | 0.050 |
Why?
|
Fibronectins | 1 | 2002 | 43 | 0.050 |
Why?
|
Breeding | 1 | 2022 | 26 | 0.050 |
Why?
|
Monocytes | 1 | 2004 | 343 | 0.050 |
Why?
|
Odorants | 1 | 2022 | 17 | 0.050 |
Why?
|
Smell | 1 | 2022 | 26 | 0.050 |
Why?
|
Terminology as Topic | 1 | 2003 | 133 | 0.050 |
Why?
|
Genes, Regulator | 1 | 2001 | 28 | 0.050 |
Why?
|
Species Specificity | 2 | 2012 | 328 | 0.050 |
Why?
|
Markov Chains | 1 | 2001 | 34 | 0.050 |
Why?
|
Motor Neurons | 1 | 2023 | 203 | 0.050 |
Why?
|
Pilot Projects | 1 | 2004 | 914 | 0.050 |
Why?
|
Cells, Cultured | 3 | 2014 | 2089 | 0.050 |
Why?
|
Up-Regulation | 2 | 2017 | 365 | 0.050 |
Why?
|
Cell Compartmentation | 1 | 2021 | 34 | 0.050 |
Why?
|
K562 Cells | 1 | 2021 | 57 | 0.050 |
Why?
|
Half-Life | 1 | 2021 | 75 | 0.050 |
Why?
|
Dogs | 1 | 2022 | 314 | 0.040 |
Why?
|
Contractile Proteins | 1 | 2020 | 14 | 0.040 |
Why?
|
Muscles | 1 | 2001 | 173 | 0.040 |
Why?
|
Tetrahydrofolate Dehydrogenase | 1 | 2000 | 15 | 0.040 |
Why?
|
Globins | 1 | 2000 | 25 | 0.040 |
Why?
|
Sperm-Ovum Interactions | 1 | 2020 | 41 | 0.040 |
Why?
|
DNA Damage | 2 | 2012 | 279 | 0.040 |
Why?
|
Cholesterol | 2 | 2012 | 252 | 0.040 |
Why?
|
Codon | 1 | 2020 | 48 | 0.040 |
Why?
|
Genes, Dominant | 1 | 2020 | 55 | 0.040 |
Why?
|
Genetic Engineering | 1 | 2021 | 111 | 0.040 |
Why?
|
HLA-DRB5 Chains | 1 | 2019 | 2 | 0.040 |
Why?
|
Butyrophilins | 1 | 2019 | 3 | 0.040 |
Why?
|
Immunoglobulins | 1 | 2000 | 76 | 0.040 |
Why?
|
Transaldolase | 1 | 1999 | 1 | 0.040 |
Why?
|
Gene Products, pol | 1 | 2019 | 8 | 0.040 |
Why?
|
Gene Products, env | 1 | 2019 | 17 | 0.040 |
Why?
|
Profilins | 1 | 2020 | 45 | 0.040 |
Why?
|
Hemagglutinins | 1 | 1999 | 17 | 0.040 |
Why?
|
Gene Products, gag | 1 | 2019 | 63 | 0.040 |
Why?
|
HLA-B35 Antigen | 1 | 1999 | 3 | 0.040 |
Why?
|
Sperm Capacitation | 1 | 2020 | 93 | 0.040 |
Why?
|
Ribonucleases | 1 | 1999 | 31 | 0.040 |
Why?
|
Immunodominant Epitopes | 1 | 1999 | 56 | 0.040 |
Why?
|
Plasmids | 1 | 2020 | 279 | 0.040 |
Why?
|
Expressed Sequence Tags | 1 | 1999 | 27 | 0.040 |
Why?
|
Muscle Contraction | 1 | 2020 | 197 | 0.040 |
Why?
|
Computer Simulation | 3 | 2014 | 457 | 0.040 |
Why?
|
Cystic Fibrosis | 1 | 2020 | 110 | 0.040 |
Why?
|
Embryonic Development | 1 | 2020 | 130 | 0.040 |
Why?
|
Nuclear Pore Complex Proteins | 1 | 2019 | 26 | 0.040 |
Why?
|
Kinetics | 1 | 2021 | 750 | 0.040 |
Why?
|
Gene Deletion | 1 | 2020 | 292 | 0.040 |
Why?
|
Cochlea | 1 | 1999 | 22 | 0.040 |
Why?
|
Major Histocompatibility Complex | 1 | 1999 | 86 | 0.040 |
Why?
|
Crystallography | 1 | 1998 | 26 | 0.040 |
Why?
|
Autoantibodies | 1 | 1999 | 172 | 0.040 |
Why?
|
Cellular Senescence | 1 | 2019 | 104 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2001 | 1093 | 0.040 |
Why?
|
Deafness | 1 | 1999 | 32 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2005 | 294 | 0.040 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 1999 | 168 | 0.040 |
Why?
|
Cell Cycle Proteins | 1 | 2021 | 384 | 0.040 |
Why?
|
Transfection | 1 | 2020 | 675 | 0.040 |
Why?
|
Chimera | 1 | 2018 | 40 | 0.040 |
Why?
|
Animals, Newborn | 1 | 1998 | 230 | 0.040 |
Why?
|
HLA Antigens | 1 | 1998 | 61 | 0.040 |
Why?
|
Reproductive Isolation | 1 | 2017 | 4 | 0.040 |
Why?
|
Sarcoma Virus, Woolly Monkey | 1 | 1997 | 1 | 0.040 |
Why?
|
Mitosis | 1 | 2019 | 208 | 0.040 |
Why?
|
Herpesvirus 4, Human | 1 | 1999 | 178 | 0.040 |
Why?
|
Chemistry, Physical | 1 | 1997 | 47 | 0.040 |
Why?
|
Platelet-Derived Growth Factor | 1 | 1997 | 17 | 0.040 |
Why?
|
Schizosaccharomyces pombe Proteins | 1 | 2018 | 73 | 0.040 |
Why?
|
Polymerase Chain Reaction | 2 | 2011 | 495 | 0.040 |
Why?
|
Chemical Phenomena | 1 | 1997 | 94 | 0.040 |
Why?
|
RNA, Long Noncoding | 1 | 2019 | 150 | 0.040 |
Why?
|
Peptide Fragments | 1 | 1999 | 400 | 0.030 |
Why?
|
HMGA2 Protein | 1 | 2016 | 4 | 0.030 |
Why?
|
HMGA Proteins | 1 | 2016 | 5 | 0.030 |
Why?
|
Genes, Neurofibromatosis 1 | 1 | 2016 | 9 | 0.030 |
Why?
|
Butadienes | 1 | 2016 | 9 | 0.030 |
Why?
|
Sequence Deletion | 1 | 2017 | 112 | 0.030 |
Why?
|
beta Catenin | 1 | 2017 | 86 | 0.030 |
Why?
|
Pyrimidinones | 1 | 2016 | 15 | 0.030 |
Why?
|
Liver | 2 | 2012 | 796 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2017 | 161 | 0.030 |
Why?
|
Niacinamide | 1 | 2016 | 32 | 0.030 |
Why?
|
DNA, Neoplasm | 1 | 2016 | 52 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2017 | 86 | 0.030 |
Why?
|
Phenylurea Compounds | 1 | 2016 | 30 | 0.030 |
Why?
|
Multiple Sclerosis | 1 | 1999 | 207 | 0.030 |
Why?
|
Anxiety | 1 | 2020 | 387 | 0.030 |
Why?
|
Nitriles | 1 | 2016 | 62 | 0.030 |
Why?
|
Drug Design | 1 | 2017 | 137 | 0.030 |
Why?
|
Pyridones | 1 | 2016 | 37 | 0.030 |
Why?
|
ras Proteins | 1 | 2016 | 77 | 0.030 |
Why?
|
Alternative Splicing | 1 | 2017 | 122 | 0.030 |
Why?
|
Mice, Nude | 1 | 2016 | 258 | 0.030 |
Why?
|
Benzimidazoles | 1 | 2016 | 56 | 0.030 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2016 | 191 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2016 | 171 | 0.030 |
Why?
|
Muscle, Skeletal | 1 | 2020 | 674 | 0.030 |
Why?
|
Blotting, Western | 1 | 2016 | 583 | 0.030 |
Why?
|
Tumor Suppressor Proteins | 1 | 2016 | 194 | 0.030 |
Why?
|
Cytoskeletal Proteins | 1 | 2016 | 196 | 0.030 |
Why?
|
Ovum | 1 | 2015 | 61 | 0.030 |
Why?
|
Survival Analysis | 1 | 2016 | 555 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2019 | 940 | 0.030 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2015 | 107 | 0.030 |
Why?
|
Cell Survival | 1 | 2017 | 559 | 0.030 |
Why?
|
Transcription Factor HES-1 | 1 | 2014 | 6 | 0.030 |
Why?
|
Bombyx | 1 | 2014 | 9 | 0.030 |
Why?
|
Adenoviridae | 1 | 2015 | 117 | 0.030 |
Why?
|
Chromosome Segregation | 1 | 2014 | 39 | 0.030 |
Why?
|
Animals, Genetically Modified | 1 | 2015 | 280 | 0.030 |
Why?
|
Age of Onset | 1 | 2015 | 170 | 0.030 |
Why?
|
Mice, Transgenic | 1 | 2018 | 1204 | 0.030 |
Why?
|
Amino Acids | 1 | 1995 | 140 | 0.030 |
Why?
|
Genetic Markers | 1 | 2014 | 116 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2016 | 846 | 0.030 |
Why?
|
SOXD Transcription Factors | 1 | 2014 | 5 | 0.030 |
Why?
|
CCCTC-Binding Factor | 1 | 2014 | 40 | 0.030 |
Why?
|
PC12 Cells | 1 | 2014 | 25 | 0.030 |
Why?
|
Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2015 | 91 | 0.030 |
Why?
|
MART-1 Antigen | 1 | 2014 | 8 | 0.030 |
Why?
|
Histone Deacetylase 6 | 1 | 2013 | 7 | 0.030 |
Why?
|
Linear Models | 1 | 2015 | 402 | 0.030 |
Why?
|
Lysine Acetyltransferase 5 | 1 | 2013 | 10 | 0.030 |
Why?
|
Cancer Vaccines | 1 | 2014 | 46 | 0.030 |
Why?
|
Protein Engineering | 1 | 2014 | 77 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2016 | 660 | 0.030 |
Why?
|
Neuroprotective Agents | 1 | 2014 | 72 | 0.030 |
Why?
|
Point Mutation | 1 | 2014 | 160 | 0.030 |
Why?
|
Mushroom Bodies | 1 | 2013 | 2 | 0.030 |
Why?
|
Cerebral Cortex | 1 | 2015 | 248 | 0.030 |
Why?
|
CpG Islands | 1 | 2014 | 211 | 0.030 |
Why?
|
Mice, 129 Strain | 1 | 2013 | 37 | 0.030 |
Why?
|
Contactins | 1 | 2012 | 4 | 0.030 |
Why?
|
Selection, Genetic | 1 | 2013 | 71 | 0.030 |
Why?
|
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2012 | 10 | 0.030 |
Why?
|
Chickens | 1 | 2013 | 89 | 0.030 |
Why?
|
Endodeoxyribonucleases | 1 | 2013 | 41 | 0.030 |
Why?
|
Macaca | 1 | 2012 | 29 | 0.030 |
Why?
|
Pan troglodytes | 1 | 2012 | 34 | 0.030 |
Why?
|
Feedback, Physiological | 1 | 2013 | 59 | 0.030 |
Why?
|
Polycomb-Group Proteins | 1 | 2012 | 21 | 0.030 |
Why?
|
Nuclear Envelope | 1 | 2012 | 48 | 0.030 |
Why?
|
Genetic Heterogeneity | 1 | 2012 | 21 | 0.020 |
Why?
|
DNA Replication Timing | 1 | 2012 | 16 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2013 | 188 | 0.020 |
Why?
|
RNA Precursors | 1 | 2012 | 74 | 0.020 |
Why?
|
Chromosomes, Fungal | 1 | 2012 | 35 | 0.020 |
Why?
|
DNA, Fungal | 1 | 2012 | 57 | 0.020 |
Why?
|
5-Methylcytosine | 1 | 2011 | 20 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2014 | 1051 | 0.020 |
Why?
|
United States | 1 | 2004 | 7385 | 0.020 |
Why?
|
Membrane Transport Proteins | 1 | 2011 | 120 | 0.020 |
Why?
|
Biosynthetic Pathways | 1 | 2010 | 18 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2010 | 112 | 0.020 |
Why?
|
Guidelines as Topic | 1 | 2011 | 153 | 0.020 |
Why?
|
RNA, Complementary | 1 | 2010 | 18 | 0.020 |
Why?
|
RNA Caps | 1 | 2010 | 17 | 0.020 |
Why?
|
Disease Progression | 1 | 2015 | 1122 | 0.020 |
Why?
|
Antigens, Nuclear | 1 | 2010 | 19 | 0.020 |
Why?
|
Methyltransferases | 1 | 2010 | 50 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2010 | 239 | 0.020 |
Why?
|
Cell Count | 1 | 2010 | 127 | 0.020 |
Why?
|
DNA Helicases | 1 | 2011 | 187 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2011 | 318 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2012 | 688 | 0.020 |
Why?
|
Embryo, Nonmammalian | 1 | 2009 | 169 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2010 | 352 | 0.020 |
Why?
|
Nucleic Acid Conformation | 1 | 2009 | 234 | 0.020 |
Why?
|
Gene Transfer Techniques | 1 | 2010 | 303 | 0.020 |
Why?
|
RNA, Double-Stranded | 1 | 2008 | 106 | 0.020 |
Why?
|
Population | 1 | 2005 | 14 | 0.020 |
Why?
|
SAIDS Vaccines | 1 | 2005 | 17 | 0.020 |
Why?
|
Gene Frequency | 1 | 2005 | 118 | 0.020 |
Why?
|
Triazoles | 1 | 2005 | 51 | 0.020 |
Why?
|
ROC Curve | 1 | 2005 | 266 | 0.010 |
Why?
|
Pyrimidines | 1 | 2005 | 130 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 445 | 0.010 |
Why?
|
Multigene Family | 1 | 2004 | 92 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2005 | 551 | 0.010 |
Why?
|
Microscopy, Phase-Contrast | 1 | 2002 | 14 | 0.010 |
Why?
|
3T3 Cells | 1 | 2002 | 108 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2005 | 1025 | 0.010 |
Why?
|
NF-kappa B | 1 | 2004 | 458 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2002 | 207 | 0.010 |
Why?
|
Extracellular Matrix | 1 | 2002 | 132 | 0.010 |
Why?
|
Reference Values | 1 | 2001 | 326 | 0.010 |
Why?
|
Biocompatible Materials | 1 | 2002 | 141 | 0.010 |
Why?
|
Cell Division | 1 | 2002 | 443 | 0.010 |
Why?
|
Fibroblasts | 1 | 2002 | 377 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2002 | 806 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2002 | 868 | 0.010 |
Why?
|
Cell Movement | 1 | 2002 | 428 | 0.010 |
Why?
|
Epitopes, B-Lymphocyte | 1 | 1999 | 16 | 0.010 |
Why?
|
Peptide Mapping | 1 | 1999 | 28 | 0.010 |
Why?
|
Molecular Mimicry | 1 | 1999 | 31 | 0.010 |
Why?
|
Cross Reactions | 1 | 1999 | 127 | 0.010 |
Why?
|
Gene Rearrangement, T-Lymphocyte | 1 | 1999 | 9 | 0.010 |
Why?
|
Biophysical Phenomena | 1 | 1999 | 22 | 0.010 |
Why?
|
Alanine | 1 | 1999 | 47 | 0.010 |
Why?
|
Diffusion | 1 | 1999 | 82 | 0.010 |
Why?
|
Biophysics | 1 | 1999 | 41 | 0.010 |
Why?
|
DNA, Complementary | 1 | 1999 | 164 | 0.010 |
Why?
|
Autoantigens | 1 | 1999 | 129 | 0.010 |
Why?
|
Static Electricity | 1 | 1999 | 163 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 1999 | 234 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 1999 | 363 | 0.010 |
Why?
|
Hydrocarbons | 1 | 1995 | 8 | 0.010 |
Why?
|
Protein Denaturation | 1 | 1995 | 67 | 0.010 |
Why?
|
Solubility | 1 | 1995 | 176 | 0.010 |
Why?
|
Streptavidin | 1 | 1994 | 32 | 0.010 |
Why?
|
beta 2-Microglobulin | 1 | 1994 | 48 | 0.010 |
Why?
|
Biotin | 1 | 1994 | 51 | 0.010 |
Why?
|
Serine Endopeptidases | 1 | 1994 | 83 | 0.010 |
Why?
|
Protease Inhibitors | 1 | 1994 | 104 | 0.010 |
Why?
|